BACKGROUND
Psychotic disorders such as schizophrenia have been associated with older-appearing brain structure, commonly quantified using the brain-age paradigm. However, it remains unclear whether these alterations are present at illness onset and whether antipsychotic treatment modifies their trajectory.
METHODS
In...
A. Roig-Herrero, S. Francey, B. O'Donoghue et al.· Schizophrenia Research· 0 citations
BACKGROUND
Individuals at clinical high risk for psychosis (CHR) present with heterogeneous combinations of positive, negative, and affective symptoms, cognitive difficulties, and functional impairment. However, reproducible multivariate links between this multidomain phenotype and brain morphology remain limited. This...
S. Vieira, Y. Alemán, L. Bici et al.· Biological Psychiatry· 0 citations
STAGES trial was a triple-blind noninferiority trial that investigated intensive psychosocial treatment with or without low-dose antipsychotics in young people with first-episode psychosis with a short duration of untreated psychosis, who were low-risk and had stable family support. Participants received cognitive beha...
K. Allott, S. Chopra, B. O'Donoghue et al.· Australian and New Zealand j...· 0 citations